Table 2 Annotation of the 23 predictive DMRs identified using 59 primary CRC tumor samples
Genome position | Gene context | Gene name | Type of DMR |
|---|---|---|---|
chr11:1861001–1862000 | Promoter | TNNI2 | hypo |
chr2:113994001–113995000 | Promoter | PAX8 | hypo |
chr2:241626001–241627000 | Promoter | AC011298 | hypo |
chr4:44679001–44680000 | Promoter | GUF1 | hyper |
chr9:110248001–110249000 | Promoter | KLF4 | hyper |
chr17:29641001–29642000 | Promoter | EVI2B | hyper |
chr17:63739001–63740000 | Promoter | CEP112 | hypo |
chr1:200977001–200978000 | Gene body | KIF21B | hypo |
chr12:66765001–66766000 | Gene body | GRIP1 | hyper |
chr13:111289001–111290000 | Gene body | NAXD | hypo |
chr19:39314001–39315000 | Gene body | ECH1 | hypo |
chr2:136279001–136280000 | Gene body | ZRANB3 | hyper |
chr7:51148001–51149000 | Gene body | COBL | hypo |
chr8:72468001–72469000 | Gene body | RP11-1102P16.1 | hyper |
chr8:99394001–99395000 | Gene body | KB-1458E12.1 | hypo |
chr16:1344001–1345000 | Gene body | RP11-616M22.7 | hypo |
chr11:12097001–12098000 | Intergenic | N/A | hyper |
chr12:90907001–90908000 | Intergenic | N/A | hypo |
chr2:75504001–75505000 | Intergenic | N/A | hypo |
chr22:18530001–18531000 | Intergenic | N/A | hyper |
chr4:153039001–153040000 | Intergenic | N/A | hypo |
chr7:34344001–34345000 | Intergenic | N/A | hyper |
chr9:139591001–139592000 | Intergenic | N/A | hypo |